Melissa Lynne Johnson, Jerome H. Goldschmidt, Ticiana Leal, Sarah Yue Wang, William E. Brady, Maen A. Hussein, Caressa Lietman, Hillarie Windish, Christophe Y. Calvet, Lola Dosunmu, Alisha Maniar, LaRee Tracy, Neal E. Ready. "TIGOS-LS, an open-label, randomized study of BMS-986489 (atigotatug + nivolumab fixed-dose combination) vs durvalumab as consolidation therapy following chemoradiotherapy in limited-stage small-cell lung cancer.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.tps8134